CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale SVP, CCO sold 952 shares at $3.40 ($3,237)
- 4 Open-market sale SVP, CFO and Treasurer sold 790 shares at $3.40 ($2,686)
- 4 Open-market sale SVP, Chief Legal Officer sold 1,060 shares at $3.40 ($3,604)
- 4 Open-market sale SVP, Chief Operating Officer sold 1,211 shares at $3.40 ($4,117)
- 4 Open-market sale CEO and President sold 4,109 shares at $3.40 ($13,971)
- 4 Open-market sale SVP, Chief Medical Officer sold 1,081 shares at $3.40 ($3,675)
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award SVP, CFO and Treasurer acquired 7,592 shares (grant or award)
Page 18 of 45 · 886 filings